Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2012 Jul;61(7):414-6.

Consider adding this drug to fight COPD that's severe

Keia Hobbs, Dionna Brown
Comment

Consider adding this drug to fight COPD that's severe

Keia Hobbs et al. J Fam Pract. 2012 Jul.

Abstract

Daily use of azithromycin, in conjunction with the usual COPD regimen, has been found to reduce acute exacerbations in patients with moderate to severe disease.

PubMed Disclaimer

Comment in

Comment on

  • Azithromycin for prevention of exacerbations of COPD.
    Albert RK, Connett J, Bailey WC, Casaburi R, Cooper JA Jr, Criner GJ, Curtis JL, Dransfield MT, Han MK, Lazarus SC, Make B, Marchetti N, Martinez FJ, Madinger NE, McEvoy C, Niewoehner DE, Porsasz J, Price CS, Reilly J, Scanlon PD, Sciurba FC, Scharf SM, Washko GR, Woodruff PG, Anthonisen NR; COPD Clinical Research Network. Albert RK, et al. N Engl J Med. 2011 Aug 25;365(8):689-98. doi: 10.1056/NEJMoa1104623. N Engl J Med. 2011. PMID: 21864166 Free PMC article. Clinical Trial.

Similar articles

See all similar articles

References

    1. Albert RK, Connett J, Bailey WC, et al. Azithromycin for prevention of exacerbations of COPD. N Engl J Med. 2011;365:689–698. - PMC - PubMed
    1. Centers for Disease Control and Prevention. Injury prevention & control: data & statistics. Available at: http://www.cdc.gov/injury/wisqars/LeadingCauses.html. Accessed April 16, 2012.
    1. Perera PN, Armstrong EP, Sherrill DL, et al. Acute exacerbations of COPD in the United States: inpatient burden and predictors of cost and mortality. COPD. 2012;9:131–141. - PubMed
    1. Jenkins CR, Jones PW, Calverley PM, et al. Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. Respir Res. 2009;10:59. - PMC - PubMed
    1. Decramer M, Celli B, Kesten S, et al. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT); a prespecified subgroup analysis of a randomized controlled trial. Lancet. 2009;374:1171–1178. - PubMed

Publication types